These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10908846)

  • 21. Current and future perspectives in advanced bladder cancer: is there a new standard?
    von der Maase H
    Semin Oncol; 2002 Feb; 29(1 Suppl 3):3-14. PubMed ID: 11894002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cisplatin, gemcitabine, and ifosfamide as weekly therapy: a feasibility and phase II study of salvage treatment for advanced transitional-cell carcinoma.
    Pagliaro LC; Millikan RE; Tu SM; Williams D; Daliani D; Papandreou CN; Logothetis CJ
    J Clin Oncol; 2002 Jul; 20(13):2965-70. PubMed ID: 12089226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase II study of a cremophor-free, polymeric micelle formulation of paclitaxel for patients with advanced urothelial cancer previously treated with gemcitabine and platinum.
    Lee JL; Ahn JH; Park SH; Lim HY; Kwon JH; Ahn S; Song C; Hong JH; Kim CS; Ahn H
    Invest New Drugs; 2012 Oct; 30(5):1984-90. PubMed ID: 22012004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gemcitabine and carboplatin in advanced transitional cell carcinoma of the urinary tract: an alternative therapy.
    Nogué-Aliguer M; Carles J; Arrivi A; Juan O; Alonso L; Font A; Mellado B; Garrido P; Sáenz A;
    Cancer; 2003 May; 97(9):2180-6. PubMed ID: 12712469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemotherapy with gemcitabine, paclitaxel, and cisplatin in the treatment of patients with advanced transitional cell carcinoma of the urothelium.
    Ecke TH; Bartel P; Koch S; Ruttloff J; Theissig F
    Oncol Rep; 2006 Dec; 16(6):1381-8. PubMed ID: 17089065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination of gemcitabine and paclitaxel is a favorable option for patients with advanced or metastatic urothelial carcinoma previously treated with cisplatin-based chemotherapy.
    Ikeda M; Matsumoto K; Tabata K; Minamida S; Fujita T; Satoh T; Iwamura M; Baba S
    Jpn J Clin Oncol; 2011 Oct; 41(10):1214-20. PubMed ID: 21903707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemotherapy with an every-2-week regimen of gemcitabine and paclitaxel in patients with transitional cell carcinoma who have received prior cisplatin-based therapy.
    Sternberg CN; Calabrò F; Pizzocaro G; Marini L; Schnetzer S; Sella A
    Cancer; 2001 Dec; 92(12):2993-8. PubMed ID: 11753976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paclitaxel, carboplatin, and gemcitabine in the treatment of patients with advanced transitional cell carcinoma of the urothelium.
    Hainsworth JD; Meluch AA; Litchy S; Schnell FM; Bearden JD; Yost K; Greco FA
    Cancer; 2005 Jun; 103(11):2298-303. PubMed ID: 15856431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring sequenced chemotherapy regimens in the treatment of transitional cell carcinoma of the urothelial tract.
    Bajorin DF
    Eur J Cancer; 2000 Jul; 36 Suppl 2():26-9. PubMed ID: 10908845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gemcitabine plus docetaxel as first-line biweekly therapy in locally advanced and/or metastatic urothelial carcinoma: a phase II study.
    Neri B; Vannini L; Giordano C; Grifoni R; Pantaleo P; Baldazzi V; Crisci A; Lapini A; Raugei A; Carini M
    Anticancer Drugs; 2007 Nov; 18(10):1207-11. PubMed ID: 17893522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Weekly chemotherapy with docetaxel, gemcitabine and cisplatin in advanced transitional cell urothelial cancer: a phase II trial.
    Pectasides D; Glotsos J; Bountouroglou N; Kouloubinis A; Mitakidis N; Karvounis N; Ziras N; Athanassiou A
    Ann Oncol; 2002 Feb; 13(2):243-50. PubMed ID: 11886001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of taxanes in the management of bladder cancer.
    Galsky MD
    Oncologist; 2005; 10(10):792-8. PubMed ID: 16314289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Metastatic breast cancer: new chemotherapy regimens with taxanes].
    Lopez M
    Clin Ter; 2005; 156(6):311-5. PubMed ID: 16463568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A phase II monocentric study of oxaliplatin in combination with gemcitabine (GEMOX) in patients with advanced/metastatic transitional cell carcinoma (TCC) of the urothelial tract.
    Theodore C; Bidault F; Bouvet-Forteau N; Abdelatif M; Fizazi K; di Palma M; Wibault P; de Crevoisier R; Laplanche A
    Ann Oncol; 2006 Jun; 17(6):990-4. PubMed ID: 16600984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Docetaxel and gemcitabine combination therapy in advanced transitional cell carcinoma of the urothelium: results of a phase II and pharmacologic study.
    Dumez H; Martens M; Selleslach J; Guetens G; De Boeck G; Aerts R; De Bruijn EA; Maes RA; van Oosterom AT
    Anticancer Drugs; 2007 Feb; 18(2):211-8. PubMed ID: 17159607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomised phase II trial of gemcitabine and paclitaxel second-line chemotherapy in patients with transitional cell carcinoma (AUO Trial AB 20/99).
    Fechner G; Siener R; Reimann M; Kobalz L; Albers P;
    Int J Clin Pract; 2006 Jan; 60(1):27-31. PubMed ID: 16409425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cisplatin, gemcitabine and paclitaxel triplet chemotherapy in 50 patients with advanced or metastatic urothelial cancer.
    Hogan TF; Lamm DL; Schuun GB; Hernadez JL; Kandzari SJ
    W V Med J; 2006; 102(2):12-5. PubMed ID: 16871949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single-agent Taxane Versus Taxane-containing Combination Chemotherapy as Salvage Therapy for Advanced Urothelial Carcinoma.
    Sonpavde G; Pond GR; Choueiri TK; Mullane S; Niegisch G; Albers P; Necchi A; Di Lorenzo G; Buonerba C; Rozzi A; Matsumoto K; Lee JL; Kitamura H; Kume H; Bellmunt J
    Eur Urol; 2016 Apr; 69(4):634-641. PubMed ID: 26264159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gemcitabine combined with sequential paclitaxel and carboplatin in patients with urothelial cancers and other advanced malignancies.
    DiPaola RS; Rubin E; Toppmeyer D; Eid J; Butzbach D; Dvorzhinski D; Capanna T; Cairdella M; Shih JW; Goodin S; Todd MB
    Med Sci Monit; 2003 Feb; 9(2):PI5-11. PubMed ID: 12601301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Front-line Treatment with Gemcitabine, Paclitaxel, and Doxorubicin for Patients With Unresectable or Metastatic Urothelial Cancer and Poor Renal Function: Final Results from a Phase II Study.
    Siefker-Radtke AO; Campbell MT; Munsell MF; Harris DR; Carolla RL; Pagliaro LC
    Urology; 2016 Mar; 89():83-9. PubMed ID: 26723185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.